Search

Your search keyword '"Bax, Caroline J."' showing total 135 results

Search Constraints

Start Over You searched for: Author "Bax, Caroline J." Remove constraint Author: "Bax, Caroline J." Language english Remove constraint Language: english
135 results on '"Bax, Caroline J."'

Search Results

2. Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study

3. Perspectives of pregnant women on broadening the scope of noninvasive prenatal testing from screening for foetal aneuploidies to prediction of adverse pregnancy outcomes: A qualitative study.

4. Decrease in Prevalence of Cleft lip, Alveolus and Palate After Nationwide Introduction of the Second-Trimester Anomaly Scan in the Netherlands.

7. Development of Nationwide Recommendations to Support Prenatal Counseling in Extreme Prematurity

8. Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial

9. Amnioinfusion Compared With No Intervention in Women With Second-Trimester Rupture of Membranes: A Randomized Controlled Trial

10. Non‐invasive prenatal testing (NIPT) in twin pregnancies affected by early single fetal demise: A systematic review of NIPT and vanishing twins.

11. Nifedipine Versus Atosiban for Threatened Preterm Birth (APOSTEL III): A Multicentre, Randomized Controlled Trial

12. Which Factors Contribute to False-Positive, False-Negative, and Invalid Results in Fetal Fibronectin Testing in Women with Symptoms of Preterm Labor?

13. Nationwide implementation of the non-invasive prenatal test

14. Low fetal fraction in cell-free DNA testing is associated with adverse pregnancy outcome: Analysis of a subcohort of the TRIDENT-2 study: analysis of a subcohort of the TRIDENT-2 study

15. Association between low fetal fraction in cell-free DNA testing and adverse pregnancy outcome: A systematic review:A systematic review

17. Risk stratification with cervical length and fetal fibronectin in women with threatened preterm labor before 34 weeks and not delivering within 7 days

18. Randomized Comparison of Nifedipine and Placebo in Fibronectin-Negative Women with Symptoms of Preterm Labor and a Short Cervix (APOSTEL-I Trial)

19. Can Previous Associations of Single Nucleotide Polymorphisms in the , , , and Genes in the Susceptibility to and Severity of Infections Be Confirmed?

20. Predictive Value of Cervical Length Measurement and Fibronectin Testing in Threatened Preterm Labor

21. Re: Cerebroplacental ratio in predicting adverse perinatal outcome: a meta-analysis of individual participant data Reply

22. Association between low fetal fraction in cell‐free DNA testing and adverse pregnancy outcome: A systematic review.

23. Remifentanil patient controlled analgesia versus epidural analgesia in labour. A multicentre randomized controlled trial

24. Antenatal Workup of Early Megacystis and Selection of Candidates for Fetal Therapy.

25. Temporizing management vs immediate delivery in early-onset severe preeclampsia between 28 and 34 weeks of gestation (TOTEM study): An open-label randomized controlled trial.

26. Prediction model of postnatal renal function in fetuses with lower urinary tract obstruction (LUTO)-Development and internal validation.

27. Transposition of the great arteries: Fetal pulmonary valve growth and postoperative neo-aortic root dilatation.

28. Nifedipine versus placebo in the treatment of preterm prelabor rupture of membranes: a randomized controlled trial Assessment of perinatal outcome by use of tocolysis in early labor- APOSTEL IV trial

29. Pessary Placement in the Prevention of Preterm Birth in Multiple Pregnancies : A Propensity Score Analysis

30. Trial by Dutch Laboratories for Evaluation of Non-Invasive Prenatal Testing. Part I - Clinical Impact

31. Nifedipine versus placebo in the treatment of preterm premature rupture of membranes. Assessment of perinatal outcome by use of tocolysis in early labor - APOSTEL IV study

32. Behavioural and neurodevelopmental outcome of 2-year-old children after preterm premature rupture of membranes : Follow-up of a randomised clinical trial comparing induction of labour and expectant management

33. Women’s experiences of monitoring the small-for-gestational age fetus by ultrasound: A qualitative study.

34. The impact of fetal gender and ethnicity on the risk of spontaneous preterm delivery in women with symptoms of preterm labor.

35. Pregnancy complications in singleton pregnancies with isolated fetal heart defects.

36. Effectiveness of a cervical pessary for women who did not deliver 48 h after threatened preterm labor (Assessment of perinatal outcome after specific treatment in early labor: Apostel VI trial).

37. Early nasogastric tube feeding in optimising treatment for hyperemesis gravidarum: the MOTHER randomised controlled trial (Maternal and Offspring outcomes after Treatment of HyperEmesis by Refeeding).

38. Midtrimester preterm prelabour rupture of membranes (PPROM): expectant management or amnioinfusion for improving perinatal outcomes (PPROMEXIL - III trial).

39. Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-Trial).

40. Serovar D and E of serogroup B induce highest serological responses in urogenital Chlamydia trachomatis infections.

41. Nifedipine Versus Atosiban for Threatened Preterm Birth (APOSTEL III): A Multicenter, Randomized Controlled Trial.

42. Authors' reply re: Cerebroplacental ratio in predicting adverse perinatal outcome: a meta‐analysis of individual participant data.

43. First‐Trimester Prediction Models Based on Maternal Characteristics for Adverse Pregnancy Outcomes: A Systematic Review and Meta‐Analysis.

44. Fetal Fraction of Cell‐Free DNA in the Prediction of Adverse Pregnancy Outcomes: A Nationwide Retrospective Cohort Study.

45. Can Previous Associations of Single Nucleotide Polymorphisms in the TLR2 , NOD1 , CXCR5 , and IL10 Genes in the Susceptibility to and Severity of Chlamydia trachomatis Infections Be Confirmed?

46. Cover Image.

47. 88: Nifedipine versus placebo in the treatment of preterm premature rupture of membranes. Assessment of perinatal outcome by use of tocolysis in early labor - APOSTEL IV study.

48. TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands.

49. Comparison of the Actim Partus test and the fetal fibronectin test in the prediction of spontaneous preterm birth in symptomatic women undergoing cervical length measurement.

50. Pessary placement in the prevention of preterm birth in multiple pregnancies: a propensity score analysis.

Catalog

Books, media, physical & digital resources